Dosing, safety, and quality of life after peanut immunotherapy trials: A long-term follow-up study is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Aimmune Therapeutics
National Institute of Allergy and Infectious Diseases
Astellas Pharma
Wallace Research Foundation
National Institutes of Health
FWCI
1.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals